Neuroschistosomiasis: clinical symptoms and pathogenesis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21849166.
- Also identified by DOI 10.1016/S1474-4422(11)70170-3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Neuroschistosomiasis, referring to schistosomal involvement of the CNS, when symptomatic, is a severe disorder in which prognosis depends largely on early diagnosis and treatment. It is an underdiagnosed disorder, but has been increasingly reported in populations in endemic areas and in tourists. CNS involvement can occur at any time during schistosomal infection. Both the brain and the spinal cord can be affected. Schistosoma mansoni and Schistosoma haematobium usually cause myelopathy, whereas Schistosoma japonicum usually causes encephalic disease. There are substantial differences in the pathogenesis, clinical presentation, and outcome of the neurological disorder, depending on the phase and clinical form of schistosomiasis in which it occurs.
Medical subject headings
- Neuroschistosomiasis
- Schistosoma haematobium
- Schistosoma japonicum
- Schistosoma mansoni